These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
941 related articles for article (PubMed ID: 29400475)
41. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836 [TBL] [Abstract][Full Text] [Related]
42. Dai R; Cai Z; Hu R; Huang Y; Fu L; Yang J; Hu K; Li H Mol Pharm; 2024 Feb; 21(2):883-894. PubMed ID: 38155100 [TBL] [Abstract][Full Text] [Related]
43. An Improved Mease RC; Kang CM; Kumar V; Banerjee SR; Minn I; Brummet M; Gabrielson KL; Feng Y; Park A; Kiess AP; Sgouros G; Vaidyanathan G; Zalutsky MR; Pomper MG J Nucl Med; 2022 Feb; 63(2):259-267. PubMed ID: 34088772 [TBL] [Abstract][Full Text] [Related]
44. Alpha-PET for Prostate Cancer: Preclinical investigation using Umbricht CA; Köster U; Bernhardt P; Gracheva N; Johnston K; Schibli R; van der Meulen NP; Müller C Sci Rep; 2019 Nov; 9(1):17800. PubMed ID: 31780798 [TBL] [Abstract][Full Text] [Related]
45. Therapeutic Multidose Preparation of a Ready-to-Use Chakraborty A; Mitra A; Tawate M; Sahoo S; Lad S; Rakshit S; Gaikwad S; Basu S; Shimpi H; Banerjee S Cancer Biother Radiopharm; 2021 Oct; 36(8):682-692. PubMed ID: 34402687 [No Abstract] [Full Text] [Related]
46. Design and Evaluation of Novel Albumin-Binding Folate Radioconjugates: Systematic Approach of Varying the Linker Entities. Benešová M; Guzik P; Deberle LM; Busslinger SD; Landolt T; Schibli R; Müller C Mol Pharm; 2022 Mar; 19(3):963-973. PubMed ID: 35192367 [TBL] [Abstract][Full Text] [Related]
47. Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy. Ruigrok EAM; van Vliet N; Dalm SU; de Blois E; van Gent DC; Haeck J; de Ridder C; Stuurman D; Konijnenberg MW; van Weerden WM; de Jong M; Nonnekens J Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1339-1350. PubMed ID: 33094433 [TBL] [Abstract][Full Text] [Related]
48. A PSMA Ligand Labeled with Cobalt-55 for PET Imaging of Prostate Cancer. Dam JH; Olsen BB; Baun C; Høilund-Carlsen PF; Thisgaard H Mol Imaging Biol; 2017 Dec; 19(6):915-922. PubMed ID: 28924629 [TBL] [Abstract][Full Text] [Related]
49. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer. Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460 [TBL] [Abstract][Full Text] [Related]
52. New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177). Zha Z; Choi SR; Li L; Zhao R; Ploessl K; Yao X; Alexoff D; Zhu L; Kung HF J Med Chem; 2022 Oct; 65(19):13001-13012. PubMed ID: 36103652 [TBL] [Abstract][Full Text] [Related]
53. Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates. Müller C; Guzik P; Siwowska K; Cohrs S; Schmid RM; Schibli R Molecules; 2018 Jun; 23(6):. PubMed ID: 29914162 [TBL] [Abstract][Full Text] [Related]
54. Umbricht CA; Benešová M; Schmid RM; Türler A; Schibli R; van der Meulen NP; Müller C EJNMMI Res; 2017 Dec; 7(1):9. PubMed ID: 28102507 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and preclinical evaluation of the 177Lu-DOTA-PSMA(inhibitor)-Lys3-bombesin heterodimer designed as a radiotheranostic probe for prostate cancer. Escudero-Castellanos A; Ocampo-García B; Ferro-Flores G; Santos-Cuevas C; Morales-Ávila E; Luna-Gutiérrez M; Isaac-Olivé K Nucl Med Commun; 2019 Mar; 40(3):278-286. PubMed ID: 30763290 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and Evaluation of Novel Iikuni S; Tarumizu Y; Tsuchihashi S; Ohara T; Watanabe H; Ono M Mol Pharm; 2022 Aug; 19(8):2725-2736. PubMed ID: 35758049 [TBL] [Abstract][Full Text] [Related]
58. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting. Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611 [TBL] [Abstract][Full Text] [Related]